Delivery Order HHSN261201000034I-HHSN26100001
Award Date
5/5/10
Potential Completion Date
3/31/15
Potential Value
$63K
Federal Agency
National Cancer Institute
Awardee
Brigham & Womens Hospital Inc.
Ultimate Awardee
Partners Healthcare System Incorporated
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02115, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to Brigham & Women's Hospital, Inc. The $143,587.50 contract supports the Cancer Genome Atlas (TCGA) program's effort to collect tissue samples and data from various types of cancer. The award is funded through the American Recovery and Reinvestment Act (ARRA) and does not have a small business set-aside designation. Brigham & Women's...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...
This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. for the Cancer Genome Atlas (TCGA) program. The $1,337,077.50 contract is to provide tissue samples and data from various types of cancer for the TCGA program, which aims to characterize the genomic changes involved in cancer. The award is not associated with a set-aside program. This delivery order is part of...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...
This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Duke University for $270,900.00. The contract is part of the NCI's Cancer Genome Atlas (TCGA) program and is funded through the American Recovery and Reinvestment Act (ARRA). Under this contract, Duke University will provide tissue samples and data from various types of cancer to support the TCGA program. The contract does not have a...
This is a $33,756 firm-fixed-price delivery order issued under the National Cancer Institute's Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract. The order was awarded to The Vanderbilt University, a leading private research institution, to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The award is funded through the American Recovery and Reinvestment Act (ARRA) and has an ultimate completion date of September...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization, under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The $120,500 award provides for the collection and supply of tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program, which is focused on comprehensive genomic characterization of cancers. This award is...
This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...